Laura Sassano07.08.11
ResMed Inc. has acquired BiancaMed Ltd., a medical technology company based in Dublin, Ireland. All outstanding shares were purchased with cash.
“We are committed to innovation in sleep and respiratory medicine and the related co-morbidities by commercializing products incorporating novel technologies,” commented Peter Farrell, Ph.D., D.Sc, A.M., ResMed’s chairman and CEO.
BiancaMed will become a part of ResMed’s newly created Ventures and Initiatives unit. ResMed estimates the acquisition will dilute earnings per share by approximately 4 cents in fiscal year 2012, excluding amortization of intangibles and one-time acquisition related costs.
“This acquisition will broaden the use of BiancaMed’s unique technology and build on BiancaMed’s momentum,” said Conor Hanley, Ph.D., CEO of BiancaMed. “As part of ResMed, we will continue to support our existing customers.”
ResMed plans to retain BiancaMed’s employees, and the office in Dublin will remain active.
“We have worked closely with BiancaMed for many years and have been investors since their inception in 2003,” Dr. Farrell said. “We believe there are many opportunities for BiancaMed's applications that will provide future growth, and we look forward to maintaining and building the BiancaMed team.”
ResMed is headquartered in San Diego, Calif.
“We are committed to innovation in sleep and respiratory medicine and the related co-morbidities by commercializing products incorporating novel technologies,” commented Peter Farrell, Ph.D., D.Sc, A.M., ResMed’s chairman and CEO.
BiancaMed will become a part of ResMed’s newly created Ventures and Initiatives unit. ResMed estimates the acquisition will dilute earnings per share by approximately 4 cents in fiscal year 2012, excluding amortization of intangibles and one-time acquisition related costs.
“This acquisition will broaden the use of BiancaMed’s unique technology and build on BiancaMed’s momentum,” said Conor Hanley, Ph.D., CEO of BiancaMed. “As part of ResMed, we will continue to support our existing customers.”
ResMed plans to retain BiancaMed’s employees, and the office in Dublin will remain active.
“We have worked closely with BiancaMed for many years and have been investors since their inception in 2003,” Dr. Farrell said. “We believe there are many opportunities for BiancaMed's applications that will provide future growth, and we look forward to maintaining and building the BiancaMed team.”
ResMed is headquartered in San Diego, Calif.